United States · Platforms & data · Seeking Alpha

Blackstone to provide Pfizer up to $1.5B to advance monthly GLP-1 for weight loss

Published by Seeking Alpha · United States 48 min ago

Veronique D — Veronique D · Seeking Alpha

Detailed summary

Blackstone will fund up to $1.5B of Pfizer's berobenatide development, with milestone payments tied to approval and sales. Read more here.

Read the full article on Seeking Alpha Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (seekingalpha.com)

Also worth reading

Automatic Data Processing, Inc. (NASDAQ:ADP) Plans Quarterly Dividend of $1.90

The Motley Fool

Dell Technologies vs. Taiwan Semiconductor: Which Technology Stock Is a Better Buy for 2027?

Your holiday credit-card bills are going up. What you can do to ease the pain.

AEVEX Q3 2026 slides: core business surges as Ukraine revenue fades

Prediction markets tied to clinical trials and drug approvals draw lawmakers' ire

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030